0 Comments
0 Shares
626 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Adalimumab Biosimilar Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. The large scale Adalimumab Biosimilar Marketing report...0 Comments 0 Shares 273 Views 0 Reviews
-
Biosimilar Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Global Executive Summary Biosimilar Market: Size, Share, and Forecast The global biosimilar market size was valued at USD 64.93 billion in 2024 and is expected to reach USD 598.55 billion by 2032, at a CAGR of 32.00% during the forecast periodThe market expansion is primarily driven by the growing number of patent expiries of blockbuster biologics and the rising prevalence of chronic...0 Comments 0 Shares 585 Views 0 Reviews
-
Biosimilar Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Regional Overview of Executive Summary Biosimilar Market by Size and Share The global biosimilar market size was valued at USD 64.93 billion in 2024 and is expected to reach USD 598.55 billion by 2032, at a CAGR of 32.00% during the forecast periodThe market expansion is primarily driven by the growing number of patent expiries of blockbuster biologics and the rising prevalence of...0 Comments 0 Shares 1K Views 0 Reviews
-
Biosimilars Market Forecast and Industry Outlook Through 2028The biosimilars market is expected to continue expanding rapidly due to ongoing advancements in biotechnology and supportive regulatory frameworks. Increasing demand for affordable biologic therapies will remain a key driver. These factors indicate strong future growth for the global biosimilars industry. The global Biosimilars Market is experiencing remarkable growth as healthcare systems...0 Comments 0 Shares 8K Views 0 Reviews
-
Global Biosimilars Market Growth Driven by Rising Biologic DemandThe Biosimilars Market is experiencing rapid growth due to the increasing demand for cost-effective alternatives to biologic drugs. Healthcare systems across the world are adopting biosimilars to reduce treatment costs while maintaining similar therapeutic effectiveness. This growing acceptance is significantly supporting the expansion of the biosimilars industry. The global Biosimilars Market...0 Comments 0 Shares 5K Views 0 Reviews
-
Global Recombinant Human Insulin Market to Reach USD 9.7 Billion by 2034 Amid Rising Diabetes BurdenAccording to a new report from Intel Market Research, the global Recombinant Human Insulin market was valued at USD 5.8 billion in 2025 and is projected to reach USD 9.7 billion by 2034, growing at a CAGR of 5.6% during the forecast period (2026–2034). This sustained growth reflects the increasing global burden of diabetes and the shift toward biotechnology-derived insulin therapies that...0 Comments 0 Shares 4K Views 0 Reviews
-
Why Pharmaceutical Companies Are Accelerating Investments in Autoimmune BiosimilarsAutoimmune Biosimilar Drug Market According to the latest report published by Data Bridge Market Research, the Autoimmune Biosimilar Drug Market The global autoimmune biosimilar drug market size was valued at USD 415.80 million in 2025 and is expected to reach USD 879.70 million by 2033, at a CAGR of 9.80% during the forecast period ...0 Comments 0 Shares 114 Views 0 Reviews
-
Why Pharmaceutical Companies Are Accelerating Investments in Autoimmune BiosimilarsAutoimmune Biosimilar Drug Market According to the latest report published by Data Bridge Market Research, the Autoimmune Biosimilar Drug Market The global autoimmune biosimilar drug market size was valued at USD 415.80 million in 2025 and is expected to reach USD 879.70 million by 2033, at a CAGR of 9.80% during the forecast period ...0 Comments 0 Shares 103 Views 0 Reviews
© 2026 Myliveroom — Live Events & Online Communities
English